Antisense Oligonucleotides to compensate loss of splicing regulation and restore normal cell physiology occurring in TDP-43 pathology

Project Details

StatusFinished
Effective start/end date14/02/22 → 31/10/22

Funding

  • Wellcome Trust (Rcl): £4,989.00